Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Valencia
Clinical trial register · Spain

Clinical Trials in Valencia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5909 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:19 UTC
5909
Studies in scope
all four open statuses
3108
Recruiting now
open to new participants
1135
Lead sponsors
across recruiting studies
Top sites
Madrid 108 Barcelona 98 Pamplona 43 Seville 42 Badalona 34

Trials with a site in Valencia

26 of 5909 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Barcelona, León, Madrid, Málaga, Pamplona, Valencia
2026-06-30
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Ferrol, Gijón, Madrid, Seville, Valencia, Vigo
2026-05-22
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Badalona, Barcelona, Granada, Madrid, Pozuelo de Alarcón, Salamanca, Usansolo, Valencia
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 3
115
Barcelona, Madrid, Seville, Valencia
2026-01-05
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Badalona, Madrid, Murcia, Seville, Valencia, Zaragoza
2025-12-19
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santiago de Compostela, Valencia, Zaragoza
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Barcelona, Gijón, Girona, Madrid, Santiago de Compostela, Seville, Valencia
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Barcelona, Jerez de la Frontera, Madrid, Santiago de Compostela, Valencia
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Badajoz, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2024-12-12
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Santiago de Compostela, Valencia
2024-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Badalona, Barcelona, Madrid, Málaga, Sabadell, Santander, Seville, Valencia
2024-04-09
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Córdoba, Sabadell, Valencia
2024-03-13
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Madrid, Sabadell, Valencia
2024-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Alicante, Barakaldo, Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Valencia
2024-01-17
Recruiting
Janssen Research & Development, LLC
Phase 1
300
Badalona, Valencia
2023-12-20
Active, closed
Janssen Research & Development, LLC
Phase 3
311
Badalona, Barcelona, Esplugues de Llobregat, Granada, Madrid, Manises, Seville, Valencia
2023-10-12
Active, closed
Janssen Research & Development, LLC
Phase 1/2
71
Alicante, Barcelona, Madrid, Seville, Valencia
2023-05-18
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
A Coruña, Alicante, Barcelona, Madrid, Seville, Valencia
2022-12-13
Recruiting
Janssen Research & Development, LLC
Phase 2
520
A Coruña, Alicante, Barcelona, Madrid, Málaga, Seville, Valencia
2022-11-11
Recruiting
Janssen Research & Development, LLC
Phase 1/2
225
Barcelona, Madrid, Santander, Valencia
2022-07-29
Active, closed
Janssen Research & Development, LLC
Phase 1/2
235
Barcelona, Córdoba, Madrid, Valencia
2022-04-11
Active, closed
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
159
Valencia
2021-10-18
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Alicante, Barcelona, Bilbao, Seville, Valencia
2021-07-15
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Barcelona, Madrid, Pamplona, Salamanca, Seville, Valencia
2021-05-19
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Badalona, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2016-11-21
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-spain/city/valencia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,909 studies in total at the last sync on 17 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Valencia that also match the filters currently applied.

How many clinical trials are recruiting in Valencia?

17 of the 26 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Valencia), 26 studies
PhaseStudiesRecruitingShare
Phase 3151057.7%
Phase 1/26223.1%
Phase 23311.5%
Phase 1113.8%
Phase 2/3113.8%

Most active sponsors

Lead sponsors with the most studies (Valencia)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC2617
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.